1,3-phenylenediamine | CAS:108-45-2

We serve 1,3-phenylenediamine CAS:108-45-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1,3-phenylenediamine

Chemical Name:1,3-phenylenediamine
CAS.NO:108-45-2
Synonyms:Benzene-1,3-diamine 
meta-Phenylenediamine (MPD) 
m-Phenylenediamine
1,3-Benzenediamine
Molecular Formula:C6H8N2
Molecular Weight:108.14100
 
Physical and Chemical Properties:
Density:1.139;
Melting point:64-66oC;
Boiling point:282-284oC;
Flash point:230oF;
Index of Refraction:1.6339;
 
Specification:
Appearance:Light brown flake
Purity(HPLC):≥99.0%
Ash:≤1.0%
Loss on drying:≤0.5%
Fe content:≤100ppm
P-Phenylenediamine:≤0.05%
O-Phenylenediamine:≤0.2%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate
 



Contact us for information like 1,3-phenylenediamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,3-Benzenediamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,m-Phenylenediamine Use and application,m-Phenylenediamine technical grade,usp/ep/jp grade.


Related News: A 40-year-old Chinese woman also tested positive. She was already in quarantine as she is related to another patient who contracted the virus.3,4-Dihydro-7-(4-bromobutoxy)-2(1H)-quinolinone manufacturer A 40-year-old Chinese woman also tested positive. She was already in quarantine as she is related to another patient who contracted the virus.4-Bromo-2-methylpyridine supplier Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.2-Bromo-6-nitrophenol vendor Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.